Innovation Pharmaceuticals Inc (IPIX)

[roiresearch]

brilacidin for covid needs to get out of the preclinical phase to be taken seriously. all the in vitro data is lovely, now let's test it in the real world. ipix gave at least 3 things in the works which need to be addressed besides the briefing package to fda
1) cdmo
2) IV B for C manufacturing time frame
3) cro

the earlier than anticipated annual report may have been to address the otcqb status in order to proceed with any number of things from fda application, grant, collaboration, etc...

IPIX alluded to having excess IV B for C for additional testing. Maybe there is a GILD/IPIX joint clinical trial in the planning phase